Arundhati has got it all wrong—the facts speak out against her romantic notions of the tribals’ fight Nirad C. Chaudhary wrote in The Continent of Circe that India’s tribals were mainly found in hill forests. This was because, he reasoned, they had been chased there by the invading Aryans, who displaced them from their river plains. In an essay published in this magazine (Capitalism: A Ghost Story, March 26), Arundhati Roy...

-The Economic Times   Shibu Joseph ( Why I am Quitting my Job, ET, March 29) suggests, tongue-in-cheek, that he should quit the drudgery of corporate life and, instead, enjoy the "freebies" given to the aam aadmi, like the right to work under the Mahatma Gandhi National Rural Employment Guarantee Act (MGNREGA).  I am not going to write on behalf of the crores of people who work in this programme, because I am...

-The Times of India   YAVATMAL: Information released under right to information (RTI) has revealed that the state government has paid Rs 2.83 crore to acquire land distributed to tribals and landless labourers under the Bhoodan movement to rehabilitate Pahur villagers displaced due to Bembla River Irrigation Project. Concerns are now being expressed that some government officials pocketed this compensation along with five land owners by forging documents and sale deeds. Sarpanch Ainuddin...

-CNN-IBN West Bengal Chief Minister Mamata Banerjee has come up with yet another bizarre advice. She is now advising people on what television channels they should watch. Addressing a gathering in North 24 Parganas, she told people to stop watching certain news channels and switch to entertainment channels instead. She told her cadres to avoid some TV channels and listen to music instead. She also criticised a section of the media for...

Industry reacts with caution to the grant of a compulsory licence to Natco, but cancer patients welcome it and hope for many more. THE first compulsory licence (CL) issued by the Indian patent office, to the local drug manufacturer Natco Pharma Ltd to sell the generic version of Bayer AG's anti-cancer drug Nexavar, has led to varied reactions. The landmark decision has also raised concerns about the outcome of cases...